// App-Quantinova.ai

TCT-51 : Comparison of Clopidogrel and Prasugrel in Patients with Unprotected Left main Disease Treated with Everolimus-Eluting Stents: Insight From the Florence Left Main-PCI Registry

Researchers

Presenter

  • Renato Valenti

Principal Investigators

  • Angela Migliorini

  • Guido Parodi

  • Ruben Vergara

  • Nazario Carrabba

  • Emilio Vincenzo Dovellini

  • David Antoniucci

Medical Centers

  • Careggi Hospital, Florence, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Myocardial infarction

  • Acute Coronary Syndromes

  • Renal insufficiency

  • Left main disease

  • Venous thrombosis

  • Diabetes

Biomarkers

  • Creatinine

Drug/Treatment

  • Clopidogrel bisulfate

  • Everolimus

  • Prasugrel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved